SOURCE: Tulip BioMed, Inc.

February 07, 2007 08:28 ET

Tulip BioMed, Inc. Announces Strategic Alliance With Premier Funding and Financial Marketing Services of Phoenix, Arizona

SAN DIEGO, CA -- (MARKET WIRE) -- February 7, 2007 -- Tulip BioMed™, Inc. (PINKSHEETS: TPBD), a developer of medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries, today announced that it has entered into a strategic alliance with Premier Funding and Financial Marketing Services ("Premier") of Phoenix, Arizona. Premier will add focus on corporate imaging and retail market awareness for existing and new shareholders.

Marc Pilkington, Director and CEO of Tulip BioMed, stated, "We are pleased to be associated with a high-powered organization such as Premier. We believe that Premier will help bring the necessary investor awareness to our publicly traded stock and build brand recognition in the financial community. Premier is well known for aggressive and successful introductions to the public markets, broker dealers, institutional investors as well as enhancing brand awareness on a national level."

Kelly Black, president and CEO of Premier, said, "We are excited to work with Tulip BioMed on incorporating various media outlets, to gain exposure for it as a portfolio company to the public markets. We are impressed with the high quality and unique market opportunities the company has been able to achieve through its disciplined growth strategies. We look forward to Tulip being involved in our 'wealth and beauty' financial marketing campaign in the very near future."

About Premier Funding

Premier Funding and Financial Marketing Services is the liaison to the investment community, finding the right financial support and solutions for the capital needs of publicly traded companies. Premier is staffed solely by female professionals with years of experience in the financial markets, creating a unique and inviting change to investor relations. Premier is focused upon providing superior corporate imaging, public relations, financial marketing, and sales support to publicly traded companies as well as private companies.

About Tulip BioMed, Inc.

Tulip BioMed, Inc. (PINKSHEETS: TPBD) is a Nevada corporation with operations based in San Diego, California. Founded in 2004, Tulip BioMed, Inc. is a medical device, biotechnology company that manufactures and distributes patented technologies for the plastic and cosmetic surgery, biopsy, orthopedic surgery, stem cell therapy and other living tissue markets. Tulip BioMed, Inc. is the exclusive licensee of patented syringe connection devices that use the worldwide recognized Tulip brand name. Tulip BioMed, Inc. manufactures, markets, and distributes medical devices, adapted with these and other patented technologies, to physicians, clinics, military, health organizations, hospitals and other distribution outlets. For more information go to: www.tulipbiomed.com. Products are available for sale at www.tulipdisposable.com.

Safe Harbor: This press release contains certain forward-looking information about Tulip BioMed, Inc., which is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as "expect(s)," "feel(s)," "believe(s)," "will," "may," "anticipate(s)," and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of Tulip BioMed, Inc., that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: our lack of operating revenue and earnings history, our need for additional capital to pursue our business strategy. We are a non-reporting company and as such do not make periodic filings with the Securities and Exchange Commission. We trade on the Pink Sheets and there can be no assurances that a liquid market will develop in our securities. Readers are cautioned not to place undue reliance on these forward-looking statements. Tulip BioMed, Inc. does not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact Information

  • CONTACT:
    Premier Funding Service
    Kelly Black
    President
    Email Contact

    Heather Kerwin
    Investor Relations
    Email Contact

    (480) 649-8224 Office
    (480) 898-0406 Fax